Dr. Axel Polack becomes the latest expert to join the Life Sciences Advisory Board at FCF Fox Corporate Finance GmbH
The Munich-based corporate financing specialist welcomes yet another highly regarded authority to its Life Sciences Advisory Board. Munich, December 15, 2020 The newest member of the Life Sciences Advisory Board at FCF Fox Corporate Finance
FCF Biotech Venture Capital Monitor – USA 11/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 11/2020”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As
FCF Life Sciences co-organizes “ACCESS CHINA Forum – Winter Online Partnering Weeks”
FCF co-organizes, together with its partner YAFO Capital, the “ACCESS CHINA Forum – Winter Online Partnering Weeks” which will be held online on January 4th-22nd, 2021. ACCESS CHINA is the most effective deal-making platform for
FCF Life Sciences Venture Capital Monitor – 10/2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – 10/2020”. The Monitor is a monthly published overview of biotechnology, pharmaceutical, medical technology and healthcare technology companies,
FCF European Infrastructure & Construction Market Study 2020 – published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF European Infrastructure & Construction Market Study – 2020”. Based on available data from European infrastructure and construction companies, the FCF Infrastructure & Construction
FCF Advanced Manufacturing Venture Capital Report – 2020 published
FCF Fox Corporate Finance GmbH is pleased to publish the “FCF Advanced Manufacturing Venture Capital Report – 2020”. The report is part of the “FCF DeepTech Series“, which is a quarterly series of reports tracking
FCF Bank Monitor – Q3 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Bank Monitor – Q3 2020”. FCF regularly engages in research on the banking sector based on available data from the most active and
FCF TMT Market Study 2020 – published
FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF TMT Market Study – 2020”.. Based on available data from European TMT companies, the FCF TMT Market Study is a detailed and comprehensive
FCF Fox Corporate Finance GmbH advises Immunic on financing the development of a potential COVID-19 drug
Gräfelfing/Munich, October 23rd, 2020 – FCF Fox Corporate Finance acts as advisor to Immunic, a biotechnology company specialized on immunology therapies, in the execution of a venture loan financing with the European Investment Bank (EIB).
FCF Valuation Monitor – Q3 2020 published
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Valuation Monitor – Q3 2020”. The FCF Valuation Monitor is a comprehensive valuation analysis for the German small / midcap market segment and